The Effect of Nebulized Epinephrine in Asthma Exacerbation in Pediatric Age Group With the Standard Treatment Compared to Standard Treatment Using Improvement PRAM Score as a Primary Outcome

Clinical trial NCT05667727 · COMPLETED

Trial details

NCT number: NCT05667727
Sponsor: Oman Medical Speciality Board
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Shortness of Breath Asthma in Children Epinephrine Causing Adverse Effects in Therapeutic Use Salbutamol Adverse Reaction

Start date: 2023-10-15
Primary completion: 2025-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.